USCAP 2025 Contemporary Issues in Breast Pathology

Overview

USCAP 2025 Contemporary Issues in Breast Pathology provides a comprehensive review and update on the pathologic diagnosis and clinical significance of benign, in situ, and malignant breast lesions identified in surgical specimens and core needle biopsies. The course emphasizes current adjunctive immunohistochemical and molecular studies that support accurate diagnosis, classification, and patient management in breast pathology.

On-demand breast pathology education — accessible anytime, anywhere.

Agenda

This course presents a detailed agenda covering practical aspects of breast pathology diagnosis, classification, and management supported by expert presentations and digital slide reviews.

• Intraductal Proliferative Lesions — Ashley Cimino-Mathews, MD
• Update on Classification and Management of LCIS — Stuart Schnitt, MD
• Contemporary Issues in Breast Core Needle Biopsies — Laura Collins, MD
• Digital Slides: Small Glandular Proliferations — Laura Collins, MD
• Digital Slides: Atypical Intraductal Proliferations — Cecily Quinn, MD, FRCPath
• Inflammatory and Reactive Lesions — Cecily Quinn, MD, FRCPath
• Papillary Proliferations — Edi Brogi, MD, PhD
• Challenging Fibroepithelial Lesions — Puay Hoon Tan, MD
• Apocrine Proliferations — Cecily Quinn, MD, FRCPath
• Digital Slides: Fibroepithelial Lesions — Puay Hoon Tan, MD
• Spindle Cell Lesions — Cecily Quinn, MD, FRCPath
• Vascular Lesions — Gregory Bean, MD, PhD
• Applications of Molecular Testing in Breast Cancer — Ashley Cimino-Mathews, MD
• Classic Triple Negative Breast Cancers, TILS and the Immune Microenvironment — Ashley Cimino-Mathews, MD
• Special Type Triple Negative Breast Cancers — Laura Collins, MD
• HER2 Low and ER Low Breast Cancers — Stuart Schnitt, MD
• Pathologic Evaluation of Specimens After Neoadjuvant Therapy — Gregory Bean, MD, PhD
• Digital Slides: Spindle Cell and Vascular Lesions — Gregory Bean, MD, PhD
• Digital Slides: Triple Negative Breast Neoplasms — Stuart Schnitt, MD
• Mucinous and Neuroendocrine Lesions — Puay Hoon Tan, MD
• Specimen Handling and Margin Evaluation — Laura Collins, MD
• Epithelial-Myoepithelial Proliferations — Puay Hoon Tan, MD
• Uncommon Clinical Scenarios — Edi Brogi, MD, PhD
• Digital Slides: Mucinous Lesions and ER+ Breast Cancers — Ashley Cimino-Mathews, MD
• Digital Slides: Unusual Breast Lesions — Edi Brogi, MD, PhD
• Uncommon Types of Invasive Breast Cancers — Gregory Bean, MD, PhD
• Contemporary Lymph Node Evaluation — Edi Brogi, MD, PhD
• Applications of AI to Breast Pathology — Stuart Schnitt, MD
• FREE SECTION: Panel Discussion and Q&A

Learning Objectives

Upon completion of this educational activity, learners will be able to:

• Describe the diagnostic criteria and clinical significance of a variety of benign, in situ, and malignant breast lesions encountered in surgical specimens and core needle biopsies
• Discuss differential diagnostic problems in breast pathology and the uses and limitations of ancillary immunohistochemical and molecular tests in arriving at the correct diagnosis
• Discuss prognostic and predictive assays in patients with breast cancer

Speakers

• Ashley Cimino-Mathews, MD
• Stuart Schnitt, MD
• Laura Collins, MD
• Cecily Quinn, MD, FRCPath
• Edi Brogi, MD, PhD
• Puay Hoon Tan, MD
• Gregory Bean, MD, PhD

Target Audience

This course is designed for practicing academic and community pathologists, as well as pathologists-in-training seeking to strengthen their expertise in breast pathology diagnosis and management.

Why This Topic Matters

USCAP 2025 Contemporary Issues in Breast Pathology addresses critical updates in breast pathology, a subspecialty that requires precise diagnostic skills supported by evolving molecular and immunohistochemical techniques. This course enhances professional competence in interpreting complex breast lesions encountered in clinical practice.

As breast pathology continues to adapt to new diagnostic tools and classifications, this course, offered through MedHub Central, supports pathologists in maintaining current knowledge essential for patient care and clinical decision-making in breast diseases.